AMDL Announces Meeting With U.S. FDA on January 25th
December 18 2006 - 1:21PM
PR Newswire (US)
TUSTIN, Calif., Dec. 18 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), developer and marketer of tests for the early detection
of cancer and other serious diseases, announced today that it will
meet with the U.S. Food and Drug Administration (FDA) on January
25, 2007 to discuss completed studies previously requested by the
FDA about AMDL's DR-70(R) cancer test kit and colorectal cancer.
"We believe the data on the ability of DR-70(R) to monitor
colorectal cancer is compelling," said Gary L. Dreher, AMDL CEO.
"The Company's primary objective continues to be to receive FDA
clearance to market this product, which would simultaneously
increase market awareness and acceptance in the international
marketplace." About AMDL AMDL, Inc. (AMEX:ADL), headquartered in
Tustin, California, is a theranostics company, involved in the
detection and treatment of the same disease, cancer. AMDL is the
inventor, developer and worldwide marketer through exclusive
distribution agreements of the DR-70(R) non-invasive cancer blood
test, which has demonstrated its ability to detect the presence in
humans of up to 14 cancers 84 percent of the time overall. Clinical
trials of DR-70(R) have been conducted in China, Canada, Taiwan and
Turkey. Cancers that can be detected are colon, breast, stomach,
liver, rectal, ovarian, cervical, esophageal, thyroid, pancreatic,
trophoblastic and malignant lymphoma. DR-70(R) can detect many
kinds of cancer using a single tube of blood, eliminating the need
for costly, multiple tests. AMDL also owns a combination immunogene
therapy technology that is a possible treatment for those already
diagnosed with cancer and could eventually be used as a vaccine to
protect patients known to be at risk because of a family history
for certain types of cancer. The combination therapy both builds
the body's immune system and destroys cancer cells. More
information about AMDL and its additional products can be obtained
at http://www.amdlcorporate.com/. Forward-Looking Statements
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's partners that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, and other
risks detailed from time to time in the Company's filings with the
Securities and Exchange Commission. The actual results may differ
materially from those contained in this press release. The Company
disclaims any obligation to update any statements in this press
release. Contact: AMDL, Inc. Gary L. Dreher President & CEO
(714) 505-4460 DATASOURCE: AMDL, Inc. CONTACT: Gary L. Dreher,
President & CEO of AMDL, Inc., +1-714-505-4460 Web site:
http://www.amdlcorporate.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024